Improvement of risk assessment in cutaneous melanoma (CM) by a prognostic 31-gene expression profile (31-GEP) test over AJCC-based staging alone

Main Article Content

Giselle Prado
Robert W Cook
Kyle R Covington
Federico A Monzon
Darrell S Rigel



Abstract not available.


Disclosures: Study sponsored by Castle Biosciences.


Copyright 2018 SKIN

Most read articles by the same author(s)

1 2 3 > >>